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Here, we investigated the properties of presynaptic N-methyl-D-
aspartate receptors (pre-NMDARs) at corticohippocampal excitatory
connections between perforant path (PP) afferents and dentate
granule cells (GCs), a circuit involved in memory encoding and cen-
trally affected in Alzheimer’s disease and temporal lobe epilepsy.
These receptors were previously reported to increase PP release
probability in response to gliotransmitters released from astrocytes.
Their activation occurred even under conditions of elevated Mg2+
and lack of action potential firing in the axons, although how this
could be accomplished was unclear. We now report that these pre-
NMDARs contain the GluN3a subunit conferring them low Mg2+
sensitivity. GluN3a-containing NMDARs at PP-GC synapses are pre-
ponderantly presynaptic vs. postsynaptic and persist beyond the
developmental period. Moreover, they are expressed selectively at
medial—not lateral—PP axons and act to functionally enhance release
probability specifically of the medial perforant path (MPP) input to GC
dendrites. By controlling release probability, GluN3a-containing pre-
NMDARs also control the dynamic range for long-term potentiation
(LTP) at MPP-GC synapses, an effect requiring Ca2+ signaling in astro-
cytes. Consistent with the functional observations, GluN3a subunits in
MPP terminals are localized at sites away from the presynaptic release
sites, often facing astrocytes, in line with a primary role for astrocytic
inputs in their activation. Overall, GluN3A-containing pre-NMDARs
emerge as atypical modulators of dendritic computations in the
MPP-GC memory circuit.
presynaptic | NMDAR | GluN3a | plasticity | astrocyte
Excitatory projections from the entorhinal cortex (EC) to thedentate gyrus (DG) play a central role in memory encoding
(1) and are also severely impacted in humans affected by
Alzheimer’s disease (AD) and temporal lobe epilepsy (TLE) (2),
critically contributing to the dysfunctions typical of these patholo-
gies (3, 4). All EC projections to DG make glutamatergic synapses
onto dentate granule cells (GCs) but with different functional
properties depending on the afferents coming from the lateral
perforant path (LPP) or medial perforant path (MPP). MPP syn-
apses show higher presynaptic release probability than LPP synap-
ses (5). Another difference is in the susceptibility to pathology, with
LPP (but not MPP) synapses showing release probability changes in
epilepsy models (6), preferential amyloid-β deposition (7), earlier
susceptibility in AD (8), and reduced plasticity with age (9). The
reasons for such differences are unknown.
We and others have previously shown that perforant path (PP)
projections onto dentate GCs are modulated by astrocytes not
only through high expression of membrane glutamate trans-
porters but also, via gliotransmitter release onto ifenprodil-
sensitive presynaptic N-methyl-D-aspartate (NMDA) receptors
(pre-NMDARs) (10). Visualized by electron microscopy (EM),
GluN2b-containing pre-NMDARs are typically located in PP
terminals away from the synaptic cleft, directly facing astrocytic
membranes (10, 11). The presence of direct astrocyte–PP axon
contacts is supported by rabies virus tracing studies (12). Rabies
virus retrogradely labels presynaptic cells: in this case, it traveled
from the infected PP projections to a portion of DG astrocytes,
consistent with the existence of dedicated astrocyte-to-axon release
sites with specialized release machinery (10, 11).
Dynamic modulation of PP release can be elicited by astrocyte
stimulation (e.g., via direct depolarization or on activation of
astrocytic purinergic G protein-coupled receptor P2Y1). Con-
sistently, inhibition of astrocytic signaling by blocking P2Y1 recep-
tors, internal Ca2+ elevation, or exocytosis eliminates the astrocyte
modulation (10, 13–15). Moreover, astrocyte signaling via type
1 tumor necrosis factor-α receptors (TNFR1s), activated by
pathological levels of the cytokine, changes PP release probability
persistently (14). Surprisingly, all of these presynaptic effects of
astrocytes were observed in the presence of 2 mM extracellular
Mg2+, suggesting that pre-NMDARs in DG have low Mg2+ sen-
sitivity, despite containing GluN2b subunits.
NMDARs have been implicated both in physiological pro-
cesses, such as memory formation, and in pathological ones, such
as those underlying drug addiction, AD, schizophrenia, or stroke
Significance
We previously identified a mechanism controlling transmitter
release probability at perforant path (PP)–granule cell excitatory
synapses, a memory-related circuit that goes awry in Alzheimer’s
disease and temporal lobe epilepsy. We found that the mecha-
nism involves activation of presynaptic N-methyl-D-aspartate
receptors (pre-NMDARs) by astrocytes but could not explain its
specificities, notably why pre-NMDARs were activated in condi-
tions in which classical NMDARs are not. We show that pre-
NMDARs (i) contain an atypical subunit, GluN3a, responsible
for their properties and (ii) are localized in PP terminals facing
astrocytes, restricted to a subset of PP afferents and controlling
only the synapses made by those afferents. This circuit-specific
modulatory mechanism by astrocytes may be important for
memory processing and its alterations in pathological conditions.
Author contributions: I.S. and A.V. designed research; I.S., M.A.D.C., R.A., H.S., and R.L.
performed research; I.S., M.A.D.C., R.A., and R.L. analyzed data; H.S. characterized and
maintained GluN3a−/− colonies and related littermate controls; R.L. designed electron
microscopy experiments; and I.S., M.A.D.C., and A.V. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission. P.J.S. is a guest editor invited by the Editorial Board.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
See Commentary on page 13166.
1I.S., M.A.D.C., and R.A. contributed equally to this work.
2To whom correspondence may be addressed. Email: andrea.volterra@unil.ch.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1816013116/-/DCSupplemental.
Published online May 31, 2019.



































(reviewed in refs. 16 and 17). While a majority of these processes
involve NMDARs located on the postsynaptic membrane, pre-
synaptic localization of NMDARs permits a unique way to mod-
ulate synaptic strength by changing release probability and thus,
efficacy of synaptic transmission. In the hippocampal PP, a single
presynaptic varicosity is contacted by multiple postsynaptic spines
(18, 19), allowing a presynaptic change at a single bouton to
simultaneously modulate the strength at multiple postsynapses. In
addition to our observations (10, 11), other studies reported data
consistent with the presence of pre-NMDAR at PP-GC synapses,
notably ifenprodil-sensitive ones (20). Moreover, NMDARs with
presynaptic location have been increasingly reported and func-
tionally investigated in several brain regions, including cerebellum,
cortex, and hippocampus (21–35). However, there have also been
reports challenging the above observations (36, 37) and raising
debate about the existence of pre-NMDAR (38). One pervasive
difficulty in prior studies was distinguishing true pre-NMDAR
activation from unintentional somatodendritic NMDAR activa-
tion in a presynaptic cell, which could then spread to the axon
(37). In this respect, hippocampal PP provides an ideal system to
isolate somatic and axonal components, because PP axons can
span over a millimeter between source EC pyramidal cells and
target GC in the hippocampus.
Pre-NMDAR expression seems to vary both with the circuits
studied and with age (34, 39–43). Subunit composition also has a
large effect on receptor function. Structurally, NMDARs are
tetramers that can be composed of two GluN1 subunits and two
GluN2 and/or GluN3 subunits. The exact subunit composition
will determine the kinetics of the NMDAR channel, its Mg2+
sensitivity, and Ca2+ permeability (reviewed in ref. 44). In-
corporation of GluN2c, GluN2d (45), or GluN3 subunits dras-
tically lowers Ca2+ permeability and voltage-dependent Mg2+
block (reviewed in refs. 16 and 46), allowing, in some instances,
receptor opening even at resting membrane potential (47, 48).
This property is shared by NMDARs found to use unconven-
tional metabotropic signaling via conformational changes with-
out ion flux through the channel (49, 50).
Some of the receptor subunits are developmentally regulated.
For example, GluN3a reaches peak whole-brain expression at
∼P8 and gradually decreases with maturation (34, 51, 52).
However, at certain afferents, GluN3 expression was reported to
persist well into adulthood (reviewed in ref. 46).
Since pre-NMDARs at PP-GC synapses have low Mg2+ sensi-
tivity, we tested whether metabotropic signaling or incorporation
of subunits, like GluN3a, accounted for their specific properties.
Results
Transient Local NMDA Application Increases Release Probability at
PP-GC Synapses. GluN2b-containing pre-NMDARs on PP axon
terminals respond to targeted gliotransmitter release from astro-
cytes by increasing release probability of PP-GC synapses (10). To
better examine the role and properties of these pre-NMDARs, we
now stimulated them via brief local puff applications of exogenous
NMDA (5 μM) while monitoring α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR)-mediated miniature
excitatory postsynaptic currents (mEPSCs) in patched GCs. We
used experimental conditions apt at minimizing activation of
NMDARs in GCs (10), including 2 mM Mg2+ and tetrodotoxin
(TTX) in the bathing medium, the high-affinity NMDAR blocker
(MK-801; 1 mM) in the patch pipette, and hyperpolarization of
the patched GC at −80 mV (Fig. 1A). Dependably, our NMDA








































































































































































































Fig. 1. Puff application of NMDA increases release probability at PP-GC synapses of juvenile mice. (A) Schematic drawing of the experimental approach.
mEPSCs were recorded from a patched GC before and after focal NMDA puff application (14) in artificial cerebrospinal fluid (aCSF) containing 2 mM Mg2+,
TTX, and picrotoxin (PTX). Activation of GC NMDARs was minimized by hyperpolarizing the cell and dialyzing it with intracellular MK-801 (10). (B) Example
synaptic current traces showing increased mEPSC frequency after 5 μM NMDA puff. Detected events are indicated by tick marks above traces. (C) Group data
showing decreased interevent interval (IEI; KS test, n = 453 vs. 473 events) and increased mEPSC frequency on NMDA puff. Significance: *paired t test P < 0.05;
#P < 0.05. (D) mEPSC amplitude and kinetics were not affected by NMDA. (E) Puff-induced increase in mEPSC frequency was achieved at NMDA
concentrations ≥2 μM (Kruskal–Wallis test, P = 0.025; multiple comparisons at 95% confidence value, n = 5–8 each, *P < 0.05).


















































changing events’ amplitude and kinetics (Fig. 1D), consistent with
a presynaptic effect. To exclude artifacts of the puff application
(e.g., mechanic stimulation of nearby astrocytes), we performed
identical puffs into the tissue without NMDA [artificial CSF
(aCSF) solution] and observed no potentiation. Likewise, NMDA
applied at 0.5 μM was ineffective, whereas at 2 μM, it increased
mEPSC frequency (Fig. 1E), suggesting a low micromolar threshold
for its action at pre-NMDARs.
Pre-NMDARs Do Not Function as Autoreceptors for Tonic Control of
Basal Glutamate Release.We then investigated whether pre-NMDARs
at PP-GC synapses tonically regulate spontaneous glutamate release
as reported at various cortical and hippocampal connections (22, 34,
45, 53). To this end, we bath applied the broad-spectrum NMDAR
antagonist D-2-amino-5-phosphonovalerate (D-APV) (50 μM)
and looked for mEPSC changes (Fig. 2A). In fact, no change
was observed in mEPSC frequency (Fig. 2B), amplitude, or kinetics
(Fig. 2C). Therefore, pre-NMDARs at PP-GC synapses do not
function as autoreceptors involved in modulating the basal release
probability.
Activity-Dependent Pre-NMDARs Stimulation Changes Release Probability
at MPP but Not LPP Synapses.To investigate whether pre-NMDARs at
PP-GC synapses are activated by evoked glutamate release, we
performed paired pulse stimulations of PP fibers and recorded
evoked EPSCs (eEPSCs) in GCs. We stimulated MPP and LPP
afferents separately and compared the effect of pre-NMDARs at
the two distinct inputs on GCs. Because pre-NMDARs at PP
terminals contain GluN2b (10) and because GluN2b-containing
NMDARs at PP-GC synapses are preponderantly presynaptic
(10, 13, 15, 20), we used for these experiments the GluN2b-
selective antagonist ifenprodil (3 μM). Application of the drug
caused combined decrease in eEPSC amplitude and increase in
evoked paired pulse ratio (PPR), generally interpretable as a
pure presynaptic effect (Fig. 2 D and E). However and surpris-
ingly, this effect was restricted to MPP synapses, whereas ifenprodil
produced no effect at LPP synapses (Fig. 2 D and E). To exclude
that this depended on a larger readily releasable pool (RRP) or on
an action of pre-NMDARs at LPP synapses on RRP replenishment
rate rather than on release probability, we applied a long train of
pulses (30 Hz) sufficient to deplete the RRP (54) (SI Appendix, Fig.
S1). However, ifenprodil was still devoid of any effect, while low-
ering external Ca2+ (1 mM), which reduces RRP size, produced the
expected functional changes (54). Therefore, modulation of release
probability by GluN2b-containing pre-NMDAR is a circuit-specific
feature of MPP-GC synapses.
Removal of GluN3a Subunit Abolishes Pre-NMDAR–Dependent
Modulation of MPP Synapses but Has No Effect at LPP Synapses.
The effect of NMDA on mEPSCs at MPP-GC synapses is puz-
zling considering that ifenprodil-sensitive GluN2b confers to
NMDAR high Mg2+ sensitivity requiring depolarization-dependent
channel unblocking, while NMDA increased mEPSC frequency
(Fig. 1) in the presence of 2 mM extracellular Mg2+. This result
could be explained if pre-NMDARs acted metabotropically (49,
50) or contained additional subunits, such as GluN2c, GluN2d
(45), or GluN3a, which reduce Mg2+ sensitivity (16). The first hy-
pothesis was discarded, because 7-chlorokinurenic acid (100 μM), a
drug that abolishes NMDAR ion flux but does not affect the re-























































































































































































































































Fig. 2. Pre-NMDARs at PP-GC synapses lack activation under basal conditions but are recruited by electrical stimulation of MPP (but not LPP) afferents. (A)
Example traces in a GC showing no changes in mEPSC frequency after bath application of the broad-spectrum NMDAR antagonist D-APV and its washout. (B)
Group data showing that mEPSC frequency and interevent interval (IEI) were unaffected on D-APV application and subsequent washout (KS and paired
t tests). (C) Likewise, mEPSC amplitude and kinetics were not affected by D-APV. (D, Upper) Representative paired pulse eEPSC responses in a GC in response
to MPP (green) or LPP (red) stimulation in control condition and on application of 3 μM ifenprodil (blue). (D, Lower) Representative time course of ifenprodil
effect on PPR at depressing MPP (PPR < 1) and facilitating LPP (PPR > 1) synapses (black lines are five-point running averages). (E) Ifenprodil application caused
significant decrease in pulse 1 amplitude and increase in PPR at MPP but not LPP synapses (paired t test). *P < 0.05; **P < 0.01.



































ifenprodil on eEPSC amplitude and PPR (SI Appendix, Fig. S2). To
start addressing the second hypothesis, we exploited availability of
GluN3a knockout mice in the laboratory (GluN3a−/−) (51). Contrary
to what was observed in wild-type mice (Fig. 1), NMDA puff in the
knockouts did not change mEPSC frequency (Fig. 3 A and B),
amplitude, or kinetics (Fig. 3C), revealing a necessary role for the
GluN3a subunit in the presynaptic action of the drug. GluN3a re-
moval per se did not affect baseline function of unstimulated PP-GC
synapses (GluN3a−/− vs. wild type: mEPSC frequency, 1.91 ± 0.36 vs.
1.41 ± 0.13 Hz, t tests: P > 0.10; amplitude, 7.42 ± 0.30 vs. 6.96 ±
0.41, P > 0.38; rise time, 2.23 ± 0.13 vs. 2.08 ± 0.06, P > 0.19; decay
time, 5.52 ± 0.38 vs. 5.03 ± 0.24, P > 0.25; n = 10 vs. 22 cells,
respectively).
We then tested evoked synaptic responses at both MPP-GC
and LPP-GC synapses in GluN3a−/− mice. The input–output
curve at either connection did not differ significantly from the
curve in littermate controls (SI Appendix, Fig. S3), suggesting
that GluN3a ablation per se does not alter basal synaptic
strength. However, it induced a small but significant PPR in-
crease (Fig. 3 D, Left) selectively at MPP-GC synapses, signaling
a changed control of release probability in the absence of this
subunit. Moreover, ifenprodil application in GluN3a−/− mice did
not change PPR (Fig. 3 E, Left), at variance with its effect in
wild-type mice (Fig. 2E), suggesting that GluN3a ablation and
ifenprodil converge in affecting the same pre-NMDAR–dependent
mechanism controlling release probability at MPP-GC synapses.
Lack of GluN3a did not produce any effect on PPR at LPP-GC
synapses (Fig. 3 D, Right), even with combined ifenprodil applica-
tion (Fig. 3 E, Right), confirming absence of pre-NMDAR modu-
lation at these synapses.
GluN3a at PP-GC Synapses Is Mainly Presynaptic, Is Concentrated at
MPP Terminals, and Like Pre-NMDAR–Dependent Modulation, Persists
After Development. Our electrophysiological results strongly
suggest that GluN3a-containing pre-NMDARs are differentially
expressed at MPP vs. LPP. To probe this, we used preembedding
immunogold EM in DG slices of juvenile and young adult mice
(Fig. 4A). For each age group, we chose a representative number
of positive synapses and quantified the relative (pre vs. post)
distribution of GluN3a gold puncta at each synapse. In keeping
with functional data, puncta were found to be concentrated at
MPP terminals and almost undetectable at LPP terminals (Fig. 4
A, a and b vs. Fig. 4 A, c and d and B). While a few GluN3a
particles were observed postsynaptically, the large majority were
in MPP terminals at extrasynaptic locations away from the cleft,
often facing astrocytic membranes (Fig. 4 A, a Inset and b).
GluN3a staining in MPP terminals decreased with age but was
still clearly detected beyond development (Fig. 4 A, e and f):
particles counted at P45 were ∼50% of those at P21 (Fig. 4B).
Accordingly, ∼50% of the recorded GCs in young adult mice
showed mEPSC response to NMDA (Fig. 4 C, Left) and ∼60%
PPR response to ifenprodil (Fig. 4 C, Right).
Long-Term Potentiation at MPP-GC Synapses Is Similarly Enhanced in
GluN3a−/− Mice and in Control Mice with Blocked Astrocyte Ca2+
Signaling. Since long-term potentiation (LTP) at MPP-GC syn-
apses has been associated with presynaptic increase in glutamate
release (5), we next investigated the impact of GluN3a ablation
on synaptic plasticity in this circuit. LTP induced by high-
frequency stimulation (HFS) was compared in GluN3a−/− and
littermate controls. For these experiments, we used local field
potential recordings (Fig. 5A). On HFS, GluN3a−/− mice displayed
significantly larger LTP in the recorded fields than controls (Fig.
5B), revealing an increased dynamic range for potentiation of these
synapses in the absence of GluN3a. We next asked whether as-
trocytes are involved in this effect based on previous evidence
that astrocytes are recruited by PP axons firing and respond to
it by starting intracellular Ca2+ signaling that results in changed
release probability of PP-GC synapses (15). Taking advantage of
previously established protocols (10, 15, 55), we used wild-type
littermate mice and recorded field potential responses in fields
containing an astrocyte whole cell patched with internal solution
containing the Ca2+ chelator 1,2-Bis(2-aminophenoxy)ethane


























































































































































































GluN3a -/-A B C
D E
Fig. 3. GluN3a subunit is required for pre-NMDAR–dependent modulation of MPP but not LPP synapses. (A) Example traces and (B) group data showing that
puff-applied NMDA (5 μM) does not trigger any mEPSC frequency increase in GluN3a−/− mice at variance with the effect in wild-type mice (t test).***P < 0.005
(n = 10 vs. 8). (C) Postsynaptic current parameters (amplitude, rise, and decay time) are not changed by NMDA application in GluN3a−/− mice. (D) Group data
showing that PPRs of synaptic currents evoked by MPP stimulation (interstimulus interval = 50 ms) in GCs were larger in GluN3a−/− mice compared with wild-
type littermates (Kruskal–Wallis; n = 12 vs. 11, *P < 0.05), while PPR measured on LPP stimulation were not significantly different between the two groups (n =
10 vs. 7). (E) In GluN3a−/−mice, ifenprodil application did not change eEPSC amplitude and PPR at bothMPP and LPP synapses (paired t test: n = 5 both) at variance
with its effect in wild-type mice (Fig. 2E, MPP). KO, knockout; WT, wild type.


















































measured in these fields was significantly larger than LTP mea-
sured, in separate experiments, in analogous fields in which astro-
cytes were not patched, astrocytes were patched without BAPTA, or
a BAPTA-containing pipette was positioned proximal to the field
electrode (Fig. 5C). Therefore, blockade of Ca2+ elevations in as-
trocytes reproduces the effect on LTP seen in GluN3a−/− mice,
strongly suggesting that the two maneuvers interfere with the same
mechanism and consequently, that recruitment of pre-NMDARs in
LTP involves intermediary astrocyte signaling.
Discussion
Here, we investigated the properties of pre-NMDARs at corti-
cohippocampal PP-GC synapses. Understanding such properties
is important in view of the functional specificities of this circuit
(e.g., in memory encoding) and of its malfunctioning in condi-
tions, like multiple sclerosis, AD, and TLE. Previous work
highlighted that pre-NMDARs in this circuit are peculiar, as they
can activate paradoxically—despite containing the GluN2b sub-
unit—even in 2 mM extracellular Mg2+ and TTX (10, 14). To
explain such property, we explored unconventional modes of
NMDAR function, such as metabotropic signaling (49), and
eventually found that incorporation of a GluN3a subunit in the
receptor can account for it. The time course of GluN3a ex-
pression and function at PP terminals is also atypical: while it
classically peaks during early development (<P20) to drastically
decrease with circuit maturation (46), here the subunit persists
into early adulthood and possibly, longer (14). GluN3a immu-
noreactivity is still well detectable in MPP terminals at P45, and
functional effects of Mg2+-insensitive pre-NMDAR are present
in a good portion of P30–P40 mice but are already wiped out in
young mice lacking GluN3a.
Another intriguing property of GluN3a-containing pre-
NMDARs at PP-GC synapses is their unavailability for tonic
autoreceptor function in response to spontaneous glutamate
release. Thus, a broad-spectrum NMDAR antagonist, D-APV,
failed to affect mEPSCs frequency (Fig. 2 A–C), in stark contrast
with its effectiveness in several other brain circuits expressing
GluN3a-containing pre-NMDARs (22, 34, 45, 53). However, the
effects of exogenous NMDA on mEPSCs and of NMDAR an-
tagonists on eEPSCs and PPR indicate that pre-NMDARs ac-
tivate under conditions of enhanced glutamate release. This
could depend on spillover from neighboring synapses or on re-
lease from astrocytes or other cells. Synaptic spillover or mech-
anisms requiring glutamate diffusion at some distance seem
unlikely given the high density of glutamate transporters in
perisynaptic astrocytic processes (11) and the tight control that
they exert on extracellular glutamate at these synapses (13), likely
also preventing pre-NMDAR autoreceptor function. Release of
glutamate from astrocytes seems, therefore, the most realistic,
albeit unconventional, mechanism for pre-NMDARs activation
at PP-GC synapses. Supporting convergent evidence includes
that (i) astrocytes apparently form synaptic-like connections with
PP axons and function as their “presynaptic” input (12); (ii) pre-
NMDARs in MPP terminals are positioned mainly at sites fac-
ing astrocytes (10) (Fig. 4); (iii) astrocytic stimulation triggers
Ca2+-dependent glutamate release (10, 13), and moreover, it
increases mEPSC frequency, like NMDA application, with both
effects being ifenprodil sensitive (10, 13) (Fig. 1); and (iv) PP
axonal firing recruits astrocyte Ca2+ signaling and suppression of
this signaling depresses PP release probability (15, 56). Finally,












































































































































Fig. 4. GluN3a subunits are presynaptically expressed at MPP but not LPP axonal boutons in both juvenile and young adult mice. (A) Subcellular localization
of GluN3a in the DG. Electron micrographs show immunoparticles for GluN3a as detected using the preembedding immunogold technique. At P21 (A, a–d),
GluN3a immunoparticles in MPP (A, a and b) were preponderantly localized to the extrasynaptic plasma membrane (arrowheads) of axon terminals (at),
establishing asymmetrical synapses with spines (s) on the dendrites (Den), often facing astrocytic profiles (ast; A, a Inset); with much lower frequency, they
were also localized along the extrasynaptic plasma membrane (arrows) of dendritic spines. In contrast, LPP immunoparticles (A, c and d) were detected at low
frequency and only along the extrasynaptic plasma membrane (arrows) of GC dendritic spines. At P45 (E–H), GluN3a immunoparticles in MPP (A, e and f) were
still observed preponderantly along the extrasynaptic plasma membrane (arrowheads) of axon terminals compared with the extrasynaptic plasma membrane
(arrows) of dendritic spines but at lower frequency than at P21. GluN3a immunoparticles in LPP (A, g and h) were detected at low frequency, lower than at
P21, and only along the extrasynaptic plasma membrane (arrows) of GC dendritic spines. (Scale bars: 500 nm.) (B) Quantification of gold puncta relative
distribution within GluN3a-positive axon terminals of MPP and LPP in P21 and P45 mice [for each condition: n = 45 GluN3a-positive synapses from three mice;
one-way ANOVA on all four groups: P < 0.05, degrees of freedom = 3, F value = 365.67, Tukey post hoc: all pairwise comparisons significantly different at P <
0.05 except as indicated (n.s.)]. (C) GluN3a-dependent presynaptic modulation at MPP is observed both in juvenile (P20) and young adult (P30-40) mice. Pre-
NMDARs continue to be observed electrophysiologically into adulthood as evidenced by persistence of effects of both NMDA application (Left; fraction of
cells responding with increased mEPSC frequency in juvenile vs. young adult, n = 16 vs. 15, P < 0.01, χ2 test: χ2 statistic 8.3299, *P = 0.0039) (Fig. 1) and
ifenprodil application (Right; fraction of cells responding with eEPSC PPR change at MPP-GC synapses in juvenile vs. young adult, n = 12 vs. 7, P = 0.4192,
χ2 test: χ2 statistic 0.6553) (Fig. 2).



































showing an identical effect on the plasticity by ablating GluN3a
or perturbing Ca2+ signaling in astrocytes (Fig. 5).
GluN3a-containing NMDARs at PP-GC synapses are pre-
ponderantly presynaptic vs. postsynaptic. According to current
understanding, presence of pre-NMDARs varies widely between
different brain regions and circuits and may be tightly develop-
mentally regulated (57, 58). Consistent with such diversity, we
report a surprising specificity in pre-NMDAR localization in the
DG: GluN3a-containing receptors are selectively expressed at
MPP—not LPP—axons. Such segregation is robustly evident across
several age cohorts (Fig. 4), electrophysiological paradigms (Figs.
2 and 3), and investigative techniques: EM and electrophysiology.
It is presently unclear why there exists such a critical selectivity of
MPP vs. LPP fibers in the capacity to modulate their inputs at
nearby synapses onto the same GC. The case, however, is not
unique. Similar differential modulation of two inputs converging
onto the same target has been reported (e.g., in the cerebellum,
where Purkinje cells receive functionally distinct excitatory inputs
from PPR-depressing climbing fibers and from strongly PPR-
facilitating parallel fibers and where only the former is modu-
lated via presynaptic α2-noradrenergic receptors) (59). Given the
complexities of dendritic filtering and integration, one could
speculate that differential modulation may reflect a need of pro-
cessing inputs differently according to one or multiple of these
reasons: different electrotonic distance of the synapses (60), dif-
ferent spike timing onsets, intrinsically different activity patterns of
the originating cells, or different nature of the information conveyed
by the inputs. With respect to this latter aspect, lesion studies
brought to propose that LPP and MPP indeed convey different
information into the hippocampus (61, 62), more sensory-related
the LPP, limbic state-related the MPP (61). Moreover, infor-
mation about spatial location might be preferentially carried by
LPP afferents, while signals related to attention, motivation, and
drive might be preferentially carried by MPP ones (63). Thus,
differential modulation of one but not the other pathway may
reshape local dendritic computation, enabling pathway-specific
long-term information storage and transfer and ultimately, dif-
ferent cognitive outcomes.
In line with the above considerations, pre-NMDAR–dependent
modulation likely contributes to the large outcome differences in
physiology of MPP vs. LPP synapses [e.g., in release probability
and LTP forms (64, 65)] and in the different susceptibility to pa-
thology (3, 4). Modified LTP at MPP-GC synapses in GluN3a−/−
mice reveals the contribution of GluN3a-containing pre-NMDARs
to the properties of synaptic plasticity of these synapses. By en-
hancing release probability, pre-NMDARs strengthen MPP-GC
connectivity in conditions of sparse firing, but during high-
frequency periods, the pre-NMDAR effect may actually reduce
their dynamic range for potentiation. Thus, the enhanced LTP
seen in GluN3a−/− mice (or on suppression of astrocyte Ca2+ el-
evations) likely reflects lack of a basal “prepotentiation” state
imposed by pre-NMDARs in the normal mice. Importantly, we
have recently described that inflammation causes excessive pre-
NMDAR activation via astrocyte TNFR1-dependent signaling in
a mouse model of multiple sclerosis. Alteration of the modulatory
input in turn causes PP-GC synapses to be persistently set to a
high-release probability mode, an effect that we found to be as-
sociated to impaired contextual memory (14).
Prominent and diverse impacts of GluN3a expression on
NMDAR-dependent long-term synaptic plasticity have been
previously reported in various circuits, notably in the hippo-
campus (66–68) and visual cortex (34, 43), but astrocytes were
never described before as activators of such receptors. For in-
stance, an increase in LTP on GluN3a knockout (and decrease
on GluN3a overexpression) had been already reported in both
the CA1 hippocampus and DG (66–68), but the effects of GluN3a
were deemed to be postsynaptic, and the role of this subunit was
mainly interpreted as a “brake,” preventing synapse maturation
and full expression of NMDAR-dependent plasticity (58, 67). In
the visual cortex, GluN3a was found to be required for induction
of pre-NMDAR–dependent spike-timing dependent long-term
depression (t-LTD) at L4-to-L2/3 synapses, and its expression
was found to be regulated in an age-dependent fashion and
modulated by sensory experience in the adult life (34, 43). While
no role for astrocytes was described in the activation of these
GluN3a-containing pre-NMDARs, an earlier t-LTD study at barrel
cortex L4-to-L2/3 synapses did in fact implicate astrocytic glutamate
release as a key requirement for pre-NMDAR activation (35) but
did not explore the involvement of GluN3a.
At MPP-GC synapses, transition from the developmental pe-
riod into adulthood is accompanied by partially reduced expres-
sion of GluN3a subunits and of functional GluN3a-containing pre-
NMDARs, akin to the observations in the visual cortex. This could
identify further refinement of the circuitry with a more selected
group of MPP-GC synapses undergoing GluN3a-dependent pre-
NMDAR modulation but also, the shift to a different type of
modulation at synapses that lose expression of GluN3a but not of
other subunits, like GluN2b. Thus, GluN3a-lacking pre-NMDAR
will become Mg2+ sensitive and require more stringent conditions
for activation, like coincident depolarization of the terminals to
relieve the Mg2+ block. This switch may, therefore, restrict circum-
stances in which release probability is boosted, impacting on control
of LTP and in general, on computations of this synaptic circuit.
Future work will need to address the above points and some
additional critical aspects raised by these findings. Why is selective
modulation of the MPP input needed? What does this input carry
to GC dendritic computations that is different from the LPP input
and might require differential plasticity to enforce? What are the
implications for the pathologies selectively affecting LPP vs. MPP,
such as AD (3, 4)? Why and how are astrocytes called to partic-
ipate in this control but only at one of the two pathways? What is
the molecular effector system controlling synaptic release proba-
bility downstream of pre-NMDAR activation?








































Fig. 5. The dynamic range for HFS-LTP at MPP-GC synapses increases in mice
lacking GluN3a or on astrocyte-selective disruption of Ca2+ signaling in wild-
type mice. (A) Schematic drawing of the LTP experiment (local field potential
measures) in GluN3a−/− mice (Upper) or in wild-type animals with astrocytes
whole-cell clamped using BAPTA-containing internal solution to block Ca2+
transients (Lower). (B) Tetanic HFS (100 Hz for 1 s, repeated three times)
produces larger LTP in GluN3a−/− mice vs. wild-type mice (wild type: eight
slices, GluN3a−/−: seven slices). Statistics: KS tests on the (nonnormalized)
values between 20 and 40 min postinduction: field excitatory postsynaptic
potential (fEPSP) amplitude: KS statistics 0.266, PPR: KS statistic 0.2022. **P <
0.0001. (C) Clamping astrocytic calcium (40 mM BAPTA) increases local LTP
measured in close proximity of the patched astrocyte. *P < 0.001. WT, wild type.



















































Brain Slices. Mice were deeply anesthetized with isoflurane and decapitated
in accordance with the authorizations concerning animal experimentation
procedures of the Veterinary Office of the Canton de Vaud (Switzerland).
Horizontal hippocampal slices (350-μm thick) for electrophysiology experi-
ments were prepared from P17 to P22 mice, except for LTP (P17–P30) and age-
related (P20–P40) experiments, using a vibrating blade microtome (HM 650 V
Microm or Leica VT1000). The cold slicing solution contained (in millimolar)
62.5 NaCl, 2.5 KCl, 7 MgCl2, 0.5 CaCl2, 25 NaHCO3, 1.5 NaH2PO4, 10 glucose,
and 105 sucrose at pH 7.4 (bubbled with a mixture of 95% O2 and 5% CO2).
After cutting, slices were kept in aCSF in a submersion chamber at 34 °C for
5–6 h. aCSF used for electrophysiology recordings contained (in millimolar) 125
NaCl, 2 KCl, 2 MgCl2, 2 CaCl2 (except for a set of experiments in low Ca
2+, in
which only 1 CaCl2 was present), 25 NaHCO3, 1.2 NaH2PO4, and 10 glucose at
nominal pH 7.4 (bubbled with a mixture of 95% O2 and 5% CO2).
Electrophysiology. All recordings were performed at 34 °C. Inhibitory
γ-aminobutyric acid receptor type A-mediated currents and action potentials
were routinely blocked unless otherwise indicated by adding picrotoxin
(100 μM) and TTX (1 μM), respectively, to the recording solution. In specific
sets of experiments, NMDAR-mediated currents were blocked by adding
D-APV (50 μM), ifenprodil (3 μM), or 7-chlorokynurenic acid (100 μM) as in-
dicated. Hippocampal DG GCs were visually identified under infrared dif-
ferential interference contrast mode using an infrared camera and an
upright fixed-stage microscope (Olympus BX51WI). In many experiments,
whole-cell recordings from GCs were made with ∼3- to 5-MΩ patch pipettes
containing (in millimolar) 117.5 Cs gluconate, 17.5 CsCl, 10 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (Hepes), 0.2 ethylene glycol-bis(β-aminoethyl
ether)-N,N,N′,N′-tetraacetic acid, 8 NaCl, 2 MgATP, 0.3 NaGTP, 5 QX314, and
1 MK-801 (pH 7.2, osmolarity: 295 mOsm). AMPAR-mediated mEPSCs were
recorded from GCs kept at −80 mV holding potential in the presence of in-
tracellular MK-801 (1 mM) and 2 mM extracellular Mg2+ to minimize activation
of postsynaptic NMDARs (10). Combining GC hyperpolarization to intracellular
MK-801 was useful toward this end, as intracellular MK-801 was recently
reported to not always block NMDAR completely (69). Patched cells were kept
for at least 15 min before NMDA puff to allow MK801 to diffuse to distal
dendrites. The gap-free traces were acquired using the MultiClamp 700B
amplifier and digitized at 50 kHz using Digidata 1440. Synaptic currents were
low-pass filtered at 1 kHz using a four-pole Bessel filter. In other sets of ex-
periments, electrically evoked synaptic currents, either eEPSCs or fEPSPs, were
measured. Electrical stimulations were selectively targeted toward MPP or LPP
inputs by placing the stimulating electrode in the middle or outer one-third of
the dentate molecular layer, respectively. For paired pulse measurements, the
two pulses were separated by 50 ms (20 Hz), and each test pulse was delivered
once every 20 or 30 s. In some experiments, we utilized a 30-Hz stimulation
protocol to deplete the RRP of synaptic vesicles (54). For experiments assessing
LTP, electrodes for field measurement were inserted into the middle one-third
of the molecular layer. The LTP induction protocol consisted of two to three
HFSs of 100 pulses for 1 s each separated by an interval of 20 s; experiments
were performed in 2 mM Mg2+ and without addition of any antagonists. To
probe the role of astrocytic Ca2+ signaling in LTP, we patched an astrocyte
located proximally to the field electrode, and dialyzed it with the Ca2+ chelator
BAPTA (40 mM) (10, 13, 15).
For field recordings, stimulation strength was chosen to correspond ap-
proximately to 30–40% of the maximal response. Input–output curves were
measured by gradually incrementing the stimulation strength by 10 μA per sweep
(delivered every 30 s). The data were discarded if the series resistance changed
over 20% (for whole-cell experiments) or if the fEPSP amplitude changed over
15% in 15 min before the stimulation (for field recording experiments).
GluN3a Knockout Mice. GluN3a −/− mice (also known as NR3a −/−) were
generated as previously reported (51) and maintained as heterozygotes.
They developed normally and were not perceptibly different from littermate
controls by body weight or apparent behavior, despite that some differences
were previously reported (66). Electrophysiological investigations were
performed in homozygous GluN3a (−/−) and wild-type controls (age: P17–
P22). For the latter, we used both GluN3a+/+ littermates and B6 wild-type
mice, and since no differences were found between the two groups, we
pooled them together. After performing electrophysiological experiments,
the exact genotype of each tested mouse was determined by RT-PCR analysis
of the tails as described previously (51, 70). Mice of both genders were used.
NMDA Local Puff Application. Local puff application of aCSF or NMDA at
various concentrations (0.5–5 μM) was performed using an electronically
controlled picospritzer (PV830 pneumatic PicoPump) as previously described
(14). The ejection pipette was positioned in the dentate molecular layer, and a
single 10-s pulse (4–7 psi) was applied. Spatial diffusion was indirectly verified
in some experiments by coejecting a fluorescent dye under two-photon
imaging. At plateau, diffusion of the dye invested a spherical volume with
∼25-μm radius. Local administration avoids indirect NMDA-dependent effects
on PP axons mediated by activation of somatodendritic receptors on distal
pyramidal cells in EC.
Analysis. Continuous current traces recorded from GCs were split into 60-s
episodes and mEPSC events detected using Mini analysis software (v6.0,
Synaptosoft) under continuous user supervision. From these data, average event
frequency, amplitude, and kinetics (rise and decay time constants) were auto-
matically calculated for each experimental time point (a single 60-s stretch).
Percentage increase after NMDA application was calculated by dividing mEPSC
frequency observed after NMDA puff by baseline frequency recorded 1 min
before NMDA puff. Based on initial time course experiments examining the
NMDA effect between 1 and 30 min from puff application and previous
observations of pre-NMDAR–dependent mEPSC modulation by tumor necrosis
factor-α (14), the 20-min time was chosen as plateau of the drug effects.
Amplitudes and PPRs of the evoked currents were measured in Clampfit. PPR
was calculated as the amplitude of peak 2 divided by the amplitude of peak 1.
Statistics. Statistical significance of the observations was evaluated using
unpaired Student’s t (two sided), ANOVA, χ2, and Kolmogorov–Smirnov (KS)
tests as indicated. The cumulative distributions were compared using non-
parametric KS test. Nonparametric Kruskal–Wallis tests with multiple com-
parisons procedure were performed using Dataplot (NIST). For t tests,
normality was tested using Shapiro–Wilk (Origin 8 software; OriginLab). For
Fig. 4B, both one-way and two-way ANOVAs were performed. Results for
the one-way ANOVA are reported in Fig. 4B, and Levene’s test indicates that
population variances are significantly different at the 0.05 level. Results for
the two-way ANOVA are as follows: statistically significant difference was
found (at P < 0.05) for age and synaptic input (MPP vs. LPP) factors (Tukey
means comparison). All results are reported as averages ± SEM unless other-
wise indicated. Each experiment has been replicated multiple times (at least
three different mice). Sample sizes were chosen based on the values sufficient
to observe statistical significance in the prior studies. Randomization was
not used.
Immunohistochemistry for EM. Immunohistochemical reactions for EM were
carried out using the preembedding immunogold method described pre-
viously (71). Briefly, free-floating sections were incubated in 10% (vol/vol)
normal goat serum (NGS) diluted in Tris-buffered saline (TBS). Sections were
then incubated in an anti-GluN3a antibody [3–5 μg/mL diluted in TBS con-
taining 1% (vol/vol) NGS]. Antibody specificity was previously confirmed by
experiments in GluN3a knockout mice (72). This was followed by incubation
in goat anti-mouse immunoglobulin G coupled to 1.4-nm gold (Nanoprobes
Inc.). Sections were postfixed in 1% (vol/vol) glutaraldehyde and washed in
double-distilled water followed by silver enhancement of the gold particles
with an HQ Silver kit (Nanoprobes Inc.). Sections were then treated with
osmium tetraoxide (1% in 0.1 M phosphate buffer), block stained with
uranyl acetate, dehydrated in graded series of ethanol, and flat embedded
on glass slides in Durcupan (Fluka) resin. Regions of interest were cut at
70–90 nm on an ultramicrotome (Reichert Ultracut E; Leica) and collected on
single-slot pioloform-coated copper grids. Staining was performed on drops
of 1% aqueous uranyl acetate followed by Reynolds’s lead citrate. Ultra-
structural analyses were performed in a Jeol-1010 electron microscope.
Quantification of GluN3a Immunoreactivity. To establish the relative abun-
dance of GluN3a immunoreactivity in the MPP or LPP of the DG molecular
layer, 60-μm-thick coronal slices were processed for preembedding immu-
nogold immunohistochemistry (see above). Embedding blocks were pre-
pared using three samples of tissue per mouse from three mice at either
P21 or P45 (totaling nine blocks per age). To minimize false negatives,
electron microscopic serial ultrathin sections were cut close to the surface of
each block, as immunoreactivity decreased with depth. We estimated the
quality of immunolabeling by always selecting areas with optimal gold la-
beling at approximately the same distance from the cutting surface. Ran-
domly selected areas were then photographed from the selected ultrathin
sections and printed with a final magnification of 60,000×. We counted
immunoparticles identified in each reference area and present along the
plasma membrane in two different subcellular compartments: dendritic
spines and axon terminals. Profiles were selected for sampling when den-
dritic spines or axon terminals contained at least one gold particle.
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